| dbo:abstract |
(-)-1-Phenyl-2-propylaminopentane (also known as (-)-PPAP and N,α-dipropylphenethylamine) is a stimulant of the substituted phenethylamine class and a derivative of Selegiline. When compared with Selegiline and other substituted phenethylamines (-)-PPAP has a notably different mechanism of action and pharmacological effect. (-)-PPAP is classified as a monoaminergic activity enhancer that stimulates the impulse propagation mediated transmitter release of the neurotransmitters dopamine, norepinephrine and serotonin in the brain. Unlike stimulants such as amphetamine, which release a flood of monoamine neurotransmitters in an uncontrolled manner, (-)-PPAP instead only increases the amount of neurotransmitters that get released when a neuron is stimulated by receiving an impulse from a neighbouring neuron. Both amphetamine and (-)-PPAP promote the release of monoamines and deuteramines, however while amphetamine causes neurons to dump neurotransmitter stores into the synapse regardless of external input, (-)-PPAP does not influence the pattern of neurotransmitter release and instead releases a larger amount of neurotransmitters than normal. (-)-PPAP has no monoamine oxidase inhibitory activity. (en) 1-苯基-2-丙基氨基戊烷(又稱為N,α-二丙基苯乙胺，簡稱PPAP)，是苯乙胺及安非他命類的興奮劑，具有特殊的作用機制及效果。 苯丙氨基戊烷屬於可增強單胺類神經遞質傳導的増效劑，其可刺激腦中神經衝動傳導，令化學性觸突釋放如多巴胺、腎上腺素和血清素等神經傳遞物質。跟安非他命這類興奮劑不同的地方是，苯丙氨基戊烷不會一次釋出大量神經傳導物質，只有在神經元受鄰近的其他神經元刺激時，才會增加神經傳導物的釋出量。苯丙氨基戊烷及安非他命皆會促進單胺類的釋放。然而不論有無外界刺激，安非他命都會使神經元將庫存神經傳遞物質運往突觸；苯丙氨基戊烷則是在不改變神經遞質釋放模式的情況下，釋放出比正常量更多的神經傳遞物質.。 苯丙胺基戊烷不抑制單胺氧化酶 (zh) |
| dbo:casNumber |
784118-64-5 |
| dbo:fdaUniiCode |
UZ3Q3C2Z57 |
| dbo:pubchem |
51529346 |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Phenylpropylaminopentane.svg?width=300 |
| dbo:wikiPageID |
13643581 (xsd:integer) |
| dbo:wikiPageLength |
4243 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1106951475 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Benzofuranylpropylaminopentane dbr:Pentedrone dbr:Neurotransmitter dbr:1,3-Benzodioxolyl-N-methylpentanamine dbc:Designer_drugs dbc:Phenethylamines dbc:Stimulants dbr:Neuron dbr:Monoamine_neurotransmitter dbr:Monoamine_oxidase dbr:Stimulant dbr:Synapse dbr:Action_potential dbr:Amphetamine dbr:Norepinephrine dbc:Substituted_amphetamines dbr:Dopamine dbr:Selegiline dbr:Serotonin dbr:Substituted_phenethylamine |
| dbp:c |
14 (xsd:integer) |
| dbp:casNumber |
784118 (xsd:integer) |
| dbp:chemspiderid |
21106218 (xsd:integer) |
| dbp:h |
23 (xsd:integer) |
| dbp:image |
Phenylpropylaminopentane.png (en) |
| dbp:iupacName |
-1 (xsd:integer) |
| dbp:legalUk |
Class A (en) |
| dbp:n |
1 (xsd:integer) |
| dbp:pubchem |
51529346 (xsd:integer) |
| dbp:smiles |
CCCN[C@H]Cc1ccccc1 (en) |
| dbp:stdinchi |
1 (xsd:integer) |
| dbp:stdinchikey |
PBENSVGEGPJNFJ-CQSZACIVSA-N (en) |
| dbp:unii |
UZ3Q3C2Z57 (en) |
| dbp:width |
200 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Dopaminergics dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Reflist dbt:Serotonergics dbt:Short_description dbt:Stimulants dbt:Cascite dbt:Fdacite |
| dcterms:subject |
dbc:Designer_drugs dbc:Phenethylamines dbc:Stimulants dbc:Substituted_amphetamines |
| gold:hypernym |
dbr:Drug |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatStimulants yago:Abstraction100002137 yago:Cognition100023271 yago:Information105816287 yago:PsychologicalFeature100023100 dbo:Drug yago:Stimulation105827684 umbel-rc:DrugProduct |
| rdfs:comment |
1-苯基-2-丙基氨基戊烷(又稱為N,α-二丙基苯乙胺，簡稱PPAP)，是苯乙胺及安非他命類的興奮劑，具有特殊的作用機制及效果。 苯丙氨基戊烷屬於可增強單胺類神經遞質傳導的増效劑，其可刺激腦中神經衝動傳導，令化學性觸突釋放如多巴胺、腎上腺素和血清素等神經傳遞物質。跟安非他命這類興奮劑不同的地方是，苯丙氨基戊烷不會一次釋出大量神經傳導物質，只有在神經元受鄰近的其他神經元刺激時，才會增加神經傳導物的釋出量。苯丙氨基戊烷及安非他命皆會促進單胺類的釋放。然而不論有無外界刺激，安非他命都會使神經元將庫存神經傳遞物質運往突觸；苯丙氨基戊烷則是在不改變神經遞質釋放模式的情況下，釋放出比正常量更多的神經傳遞物質.。 苯丙胺基戊烷不抑制單胺氧化酶 (zh) (-)-1-Phenyl-2-propylaminopentane (also known as (-)-PPAP and N,α-dipropylphenethylamine) is a stimulant of the substituted phenethylamine class and a derivative of Selegiline. When compared with Selegiline and other substituted phenethylamines (-)-PPAP has a notably different mechanism of action and pharmacological effect. (-)-PPAP has no monoamine oxidase inhibitory activity. (en) |
| rdfs:label |
Phenylpropylaminopentane (en) 苯丙氨基戊烷 (zh) |
| owl:sameAs |
freebase:Phenylpropylaminopentane yago-res:Phenylpropylaminopentane wikidata:Phenylpropylaminopentane dbpedia-sh:Phenylpropylaminopentane dbpedia-sr:Phenylpropylaminopentane dbpedia-zh:Phenylpropylaminopentane https://global.dbpedia.org/id/4tp4g |
| prov:wasDerivedFrom |
wikipedia-en:Phenylpropylaminopentane?oldid=1106951475&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Phenylpropylaminopentane.png wiki-commons:Special:FilePath/Phenylpropylaminopentane.svg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Phenylpropylaminopentane |
| is dbo:wikiPageRedirects of |
dbr:C14H23N dbr:(-)-1-Phenyl-2-propylaminopentane dbr:(-)-1-phenyl-2-propylaminopentane |
| is dbo:wikiPageWikiLink of |
dbr:Prolintane dbr:Propylamphetamine dbr:List_of_adrenergic_drugs dbr:List_of_dopaminergic_drugs dbr:C14H23N dbr:(-)-1-Phenyl-2-propylaminopentane dbr:(-)-1-phenyl-2-propylaminopentane |
| is foaf:primaryTopic of |
wikipedia-en:Phenylpropylaminopentane |
